D.E. Shaw & Co’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-195,064
| Closed | -$103K | – | 3732 |
|
|
2022
Q4 | $103K | Sell |
195,064
-372,052
| -66% | -$197K | ﹤0.01% | 3125 |
|
|
2022
Q3 | $415K | Sell |
567,116
-542,039
| -49% | -$397K | ﹤0.01% | 2952 |
|
|
2022
Q2 | $1.26M | Sell |
1,109,155
-99,725
| -8% | -$114K | ﹤0.01% | 2564 |
|
|
2022
Q1 | $2.48M | Buy |
1,208,880
+51,468
| +4% | +$106K | ﹤0.01% | 2286 |
|
|
2021
Q4 | $3.33M | Sell |
1,157,412
-248,577
| -18% | -$716K | ﹤0.01% | 2011 |
|
|
2021
Q3 | $5.96M | Buy |
1,405,989
+332,989
| +31% | +$1.41M | 0.01% | 1348 |
|
|
2021
Q2 | $5.68M | Buy |
1,073,000
+765,962
| +249% | +$4.05M | ﹤0.01% | 1370 |
|
|
2021
Q1 | $1.43M | Buy |
307,038
+268,880
| +705% | +$1.25M | ﹤0.01% | 1998 |
|
|
2020
Q4 | $126K | Buy |
+38,158
| New | +$126K | ﹤0.01% | 2623 |
|
|
2017
Q4 | – | Sell |
-29,997
| Closed | -$251K | – | 2693 |
|
|
2017
Q3 | $251K | Buy |
+29,997
| New | +$251K | ﹤0.01% | 2281 |
|